Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7519395rdf:typepubmed:Citationlld:pubmed
pubmed-article:7519395lifeskim:mentionsumls-concept:C0221908lld:lifeskim
pubmed-article:7519395lifeskim:mentionsumls-concept:C0012315lld:lifeskim
pubmed-article:7519395lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:7519395lifeskim:mentionsumls-concept:C0598352lld:lifeskim
pubmed-article:7519395lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:7519395lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:7519395lifeskim:mentionsumls-concept:C0332324lld:lifeskim
pubmed-article:7519395pubmed:issue1 Pt 1lld:pubmed
pubmed-article:7519395pubmed:dateCreated1994-8-30lld:pubmed
pubmed-article:7519395pubmed:abstractTextParathyroid hormone (PTH) increases transcellular Ca2+ absorption in renal cortical thick ascending limbs and distal convoluted tubules (DCT). In cells isolated from these nephron segments, PTH increases Ca2+ uptake by a pathway that is sensitive to dihydropyridine-type agonists and antagonists (B. J. Bacskai and P. A. Friedman. Nature Lond. 347: 388-391, 1990). Patch-clamp techniques were used to identify Ca(2+)-permeable channels in DCT cells. Channel activity was detectable in cell-attached patches only in cells pretreated with PTH. Ca2+ channels exhibited prolonged open times (seconds), had a low single-channel conductance (2.1 pS), and open channel probability increased at hyperpolarizing voltages (-50 to -90 mV). Channel activity was sensitive to dihydropyridine-type compounds, nifedipine, and BAY K8644, as was Ca2+ uptake. However, Ca2+ entry was insensitive to verapamil or omega-conotoxin. These results demonstrate that these channels mediate PTH-stimulated apical membrane Ca2+ entry in DCT cells, which are the principal Ca(2+)-transporting cells of the kidney.lld:pubmed
pubmed-article:7519395pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519395pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519395pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519395pubmed:languageenglld:pubmed
pubmed-article:7519395pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519395pubmed:citationSubsetIMlld:pubmed
pubmed-article:7519395pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519395pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519395pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519395pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519395pubmed:statusMEDLINElld:pubmed
pubmed-article:7519395pubmed:monthJullld:pubmed
pubmed-article:7519395pubmed:issn0002-9513lld:pubmed
pubmed-article:7519395pubmed:authorpubmed-author:FriedmanP APAlld:pubmed
pubmed-article:7519395pubmed:authorpubmed-author:MatsunagaHHlld:pubmed
pubmed-article:7519395pubmed:authorpubmed-author:StantonB ABAlld:pubmed
pubmed-article:7519395pubmed:authorpubmed-author:GesekF AFAlld:pubmed
pubmed-article:7519395pubmed:issnTypePrintlld:pubmed
pubmed-article:7519395pubmed:volume267lld:pubmed
pubmed-article:7519395pubmed:ownerNLMlld:pubmed
pubmed-article:7519395pubmed:authorsCompleteYlld:pubmed
pubmed-article:7519395pubmed:paginationC157-65lld:pubmed
pubmed-article:7519395pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7519395pubmed:meshHeadingpubmed-meshheading:7519395-...lld:pubmed
pubmed-article:7519395pubmed:meshHeadingpubmed-meshheading:7519395-...lld:pubmed
pubmed-article:7519395pubmed:meshHeadingpubmed-meshheading:7519395-...lld:pubmed
pubmed-article:7519395pubmed:meshHeadingpubmed-meshheading:7519395-...lld:pubmed
pubmed-article:7519395pubmed:meshHeadingpubmed-meshheading:7519395-...lld:pubmed
pubmed-article:7519395pubmed:meshHeadingpubmed-meshheading:7519395-...lld:pubmed
pubmed-article:7519395pubmed:meshHeadingpubmed-meshheading:7519395-...lld:pubmed
pubmed-article:7519395pubmed:meshHeadingpubmed-meshheading:7519395-...lld:pubmed
pubmed-article:7519395pubmed:meshHeadingpubmed-meshheading:7519395-...lld:pubmed
pubmed-article:7519395pubmed:meshHeadingpubmed-meshheading:7519395-...lld:pubmed
pubmed-article:7519395pubmed:year1994lld:pubmed
pubmed-article:7519395pubmed:articleTitleEpithelial Ca2+ channels sensitive to dihydropyridines and activated by hyperpolarizing voltages.lld:pubmed
pubmed-article:7519395pubmed:affiliationDepartment of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire 03755.lld:pubmed
pubmed-article:7519395pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7519395pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7519395pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed